The Optimal Intervention Time of Bone Marrow Mesenchymal Stem Cells in Ameliorating Cardiac Fibrosis Induced by Viral Myocarditis: A Randomized Controlled Trial in Mice

Bone marrow-derived mesenchymal stem cells (BMSCs) have recently been introduced to treat cardiovascular diseases, such as myocardial infarction and dilated cardiomyopathy. Nevertheless, there are few researches focused on the application of BMSCs in treating viral myocarditis, not to mention its op...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tingting, Xie, Yuan, Huang, Jing, Li, Ping, Wang, Xuliang, Yan, Yaoyao, Xia, Tianhe, Li, Lei, Zhu, Feng, Li, Hao, Wu, Rongzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736900/
https://www.ncbi.nlm.nih.gov/pubmed/29362568
http://dx.doi.org/10.1155/2017/3258035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736900/
https://www.ncbi.nlm.nih.gov/pubmed/29362568
http://dx.doi.org/10.1155/2017/3258035

Ejemplares similares